project id: TCGA-LIHC; case submitter id: TCGA-XR-A8TD; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.11; rna integrity number: 8.2; age at index: 49; days to birth: -17908; ethnicity: hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 17908; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1030.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8174/3; primary diagnosis: Hepatocellular carcinoma, clear cell type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 585; days to sample procurement: 0; initial weight: 320.0; portion submitter id: TCGA-XR-A8TD-01A-12; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 10.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;